Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Med Case Rep ; 17(1): 421, 2023 Oct 07.
Article in English | MEDLINE | ID: mdl-37803380

ABSTRACT

BACKGROUND: Primary hyperoxaluria (PH) is a rare genetic disorder characterized by the excessive production and accumulation of oxalate. We present five cases of PH, each exhibiting varying manifestations of the disorder including a case presenting as postpartum kidney failure. Notably, three of these cases involve a previously unreported mutation. CASE PRESENTATIONS: We evaluated five Indian patients who presented with varying manifestations of PH. The first case, a 30 year old woman, presented as post-partum kidney failure and was found to be having oxalate nephropathy precipitated by dietary oxalate overload in the setting of previously undiagnosed PH. Genetic analysis revealed a previously unreported mutation in the alanine-glyoxylate aminotransferase gene. The patient underwent simultaneous kidney liver transplant. The second and third cases, 26 and 28 year old women respectively, were asymptomatic siblings of the first patient, who were diagnosed through screening. The fourth case is a 12 year boy with PH type 1 presenting as nephrolithiasis and rapidly worsening kidney function requiring combined kidney liver kidney transplant. Case 5 is a 6 year old male child with type 2 PH presenting with nephrolithiasis, nephrocalcinosis and normal kidney function. All the patients were born to consanguineous parents. CONCLUSIONS: Due to limited clinical suspicion and inadequate diagnostic resources in certain countries with limited resources, it is possible for PH to go undiagnosed. The manifestations of the disease can range from no noticeable symptoms to severe disease. Interestingly, in some individuals with primary hyperoxaluria, the disease may not exhibit any symptoms until it is triggered by a high intake of dietary oxalate.


Subject(s)
Hyperoxaluria, Primary , Kidney Calculi , Renal Insufficiency , Male , Child , Humans , Female , Adult , Hyperoxaluria, Primary/complications , Hyperoxaluria, Primary/diagnosis , Hyperoxaluria, Primary/genetics , Kidney , Oxalates
2.
Saudi J Kidney Dis Transpl ; 34(6): 570-575, 2023 Nov 01.
Article in English | MEDLINE | ID: mdl-38725207

ABSTRACT

Patients with end-stage renal disease (ESRD) are at an increased risk of hepatitis C virus (HCV) infection. This study evaluated the prevalence of HCV infection in patients with ESRD on maintenance hemodialysis (MHD) and studied the effectiveness of sofosbuvir-velpatasvir and sofosbuvir-daclatasvir regimens in these patients. This study included patients with ESRD on MHD between January 2019 and December 2021 who were screened for HCV serology status. HCV-positive patients received sofosbuvir-velpatasvir or sofosbuvir-daclatasvir. Efficacy was assessed by the sustained virological response (SVR), and safety assessments included monitoring adverse events and laboratory parameters. Out of 1330 patients, 188 patients (14.1%) were positive for anti-HCV, with Genotype 1 being the most common genotype. Of these, 106 patients were included. The majority were males (61.3%), and the mean age was 48.4 years. Hypertension (45.3%) was the most common cause of renal failure, followed by diabetes (31.1%). Most patients (63.2%) were positive for HCV in the first 2 years of their dialysis treatment. Out of 106 patients, only 54 had received blood transfusions. Ninety-four (88.7%) patients received sofosbuvir-velpatasvir, whereas 12 (11.3%) received sofosbuvir-daclatasvir. SVR at 12 and 24 weeks after stopping treatment was seen in all (100%) patients. Asthenia and fatigue were the most common adverse events (11.2%). No patients reported on-treatment virologic failure or discontinuation of treatment because of adverse events. The prevalence of HCV infection in this population was 14.1%, and treatment of HCV infection using sofosbuvir-velpatasvir or sofosbuvir-daclatasvir regimens was well tolerated and effective.


Subject(s)
Antiviral Agents , Carbamates , Drug Combinations , Heterocyclic Compounds, 4 or More Rings , Imidazoles , Kidney Failure, Chronic , Pyrrolidines , Renal Dialysis , Sofosbuvir , Valine , Humans , Male , Female , Middle Aged , Sofosbuvir/therapeutic use , Imidazoles/therapeutic use , Imidazoles/administration & dosage , Kidney Failure, Chronic/therapy , Kidney Failure, Chronic/complications , Carbamates/therapeutic use , Valine/analogs & derivatives , Valine/therapeutic use , Pyrrolidines/therapeutic use , Antiviral Agents/therapeutic use , Antiviral Agents/adverse effects , Heterocyclic Compounds, 4 or More Rings/therapeutic use , Heterocyclic Compounds, 4 or More Rings/adverse effects , Adult , Prevalence , Treatment Outcome , Hepatitis C/drug therapy , Hepatitis C/diagnosis , Hepatitis C/epidemiology , Aged , Hepacivirus/genetics , Hepacivirus/drug effects , Sustained Virologic Response , Saudi Arabia/epidemiology , Hepatitis C, Chronic/drug therapy , Hepatitis C, Chronic/diagnosis , Hepatitis C, Chronic/complications , Hepatitis C, Chronic/virology
3.
Sci Rep ; 8(1): 4091, 2018 03 06.
Article in English | MEDLINE | ID: mdl-29511225

ABSTRACT

Modern high yielding rice varieties have replaced most of the traditional cultivars in recent past. Mushk Budji, is one such short grained landrace known for its aroma and exquisite quality, however, is highly susceptible to blast disease that has led to considerable decline in its area. Mushk Budji was crossed to a triple-gene donor line, DHMAS 70Q 164-1b and followed through marker-assisted foreground and background selection in first and second backcross generations that helped to incorporate blast resistance genes Pi54, Pi1 and Pita. Marker-assisted background selection was carried out using 78 SSR and STS markers that helped to reduce linkage drag around the genes Pi54, Pi1 and Pita to 2.74, 4.60 and 2.03 Mb, respectively. The three-gene lines in BC2F2:3 were genotyped using 50 K SNP chip and revealed more than 92% genome similarity to the RP. 2-D gel assay detected differentially expressing 171 protein spots among a set of backcross derived lines, of which 38 spots showing match score of 4 helped us to calculate the proteome recovery. MALDI-TOF analysis helped to detect four significant proteins that were linked to quality and disease resistance. The improved lines expressed resistance to blast under artificial and natural field conditions.


Subject(s)
Disease Resistance , Hybridization, Genetic , Oryza/genetics , Oryza/immunology , Plant Diseases/genetics , Plant Diseases/immunology , Selection, Genetic , Electrophoresis, Gel, Two-Dimensional , Genes, Plant , Genetic Markers , Genotype , Genotyping Techniques , Plant Proteins/analysis , Polymorphism, Single Nucleotide , Proteome/analysis , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
4.
BMC Nephrol ; 18(1): 111, 2017 Mar 30.
Article in English | MEDLINE | ID: mdl-28359253

ABSTRACT

BACKGROUND: Cytokines have been found to be the important mediators during renal graft outcome. Therefore, we designed this study to investigate the role of recipients' IL-1 ß promoter (-511) and IL-1 ß exon-5 (+3954) polymorphisms with the risk of graft outcome. METHODOLOGY: We enrolled one hundred recipients of living-related renal transplants together with the age and sex matched controls from the healthy population not having any renal abnormality for this study. Genotype frequencies of the IL-1 ß promoter (-511) and IL-1 ß exon-5 (+3954) were analyzed using PCR-RFLP technique. RESULTS: Our results revealed significant differences in the healthy control group and patient group in IL 1ß +3954 (p < 0.001). The frequency of variant type TT genotype was higher in RE group as compared to SGF and showed 4 fold risk of rejection (OR = 4.54, p < 0.069) although p value was not significant. The frequency of wild type CC genotype and CT was not significant (p value 0.89 and 0.74 respectively). CONCLUSION: Our findings suggest that there is a prevalence of mutated allele of IL-1 gene cluster in our population, which may be responsible for renal dysfunction.


Subject(s)
Genetic Association Studies , Graft Rejection/epidemiology , Graft Rejection/genetics , Graft Survival/genetics , Interleukin-1beta/genetics , Kidney Transplantation/statistics & numerical data , Polymorphism, Single Nucleotide/genetics , Adolescent , Adult , Age Distribution , Allografts , Case-Control Studies , Female , Genetic Predisposition to Disease/epidemiology , Genetic Predisposition to Disease/genetics , Humans , India/epidemiology , Male , Middle Aged , Prevalence , Risk Factors , Sex Distribution , Transplantation, Homologous/statistics & numerical data , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...